Neuroprotective agent under trial for PD
Coenzyme Q-10
Ginko Biloba
NMDA antagonists
MAO-B inhibitors
Vitamin c and E
Steroids
Cox2 inhibitors
Anti apoptotic agents
Dopamine agonists
This site is for information of patients and physicians about the latest developments in the field of parkinsonism and related disorders.For treatment purpose you are advised to consult your doctor
Coenzyme Q-10
Ginko Biloba
NMDA antagonists
MAO-B inhibitors
Vitamin c and E
Steroids
Cox2 inhibitors
Anti apoptotic agents
Dopamine agonists
Posted by
Neurologist.Canada
at
4:11 PM
0
comments
Hyperthyyroidism
Hypocalcemia
Hypoglycemia
Hyperglycemia
Hypernatremia
Hyponatremia
Hypomagnesemia
Splenorenal shunt
Osmotic demyelination
Posted by
Neurologist.Canada
at
4:09 PM
0
comments
Neuroleptics
Dopamine agonists
Anticonvulsants like phenytoin,carbamazepine,phenobarbitone,ethosuxemide ,valproate
Trycyclic anti depressants
Calcium channel blockers
Diazepam
Domperidone
Inderal
Chloroxazone
Posted by
Neurologist.Canada
at
4:01 PM
0
comments
Botulinum toxin (BOTOX) is used in the treatment of spasticity in children.Doses of up to 29 units per kilogram has been used in some studies.Body weight,muscle size,location of muscle and degree of spasticity has to be considered in selecting the dosages.However there are no studies to indicate how much dose should be used to saturate neuromuscular junction is unknown.botox when injected will diffuse into the muscle and block the nearby neuromuscular junction.This causes defective acetylcholine release.increasing the amount of saline used for dilution increase the diffusion.Local anaesthetic may be required before injecting botox in children.
Posted by
Neurologist.Canada
at
3:39 PM
0
comments